|Statement||edited by A.J. Baertschi and J.J. Dreifuss.|
|Contributions||Baertschi, A. J., Dreifuss, J. J., International Brain Research Organization., IBRO World Congress (1st : 1982 : Lausanne, Switzerland)|
|LC Classifications||QP356.4 .N4837 1982|
|The Physical Object|
|Pagination||xvi, 368 p. :|
|Number of Pages||368|
|LC Control Number||83138559|
In: Baertschi A J, Dreifuss J J (Eds) Neuroendocrinology of Vasopressin, Corticoliberin, and Opiomelanocortins. Academic Press, New York, pp. - AVP AND OT DURING STRESS Mormede P () The vasopressin receptor antagonist dPTyr(Me)AVP does not prevent stress-induced ACTH and corticosterone release. Nature - Cited by: Vasopressin is known to mediate its action on the kidney through increasing the concentrations of cyclic AMP. As vasopressin is widely distributed in many extra hypothalamic areas of the brain and can be shown to act centrally, we have investigated the effect of vasopressin on cyclic AMP levels in homogenates of the striatal and locus coeruleus by: 4. Journals & Books; Help; Regulatory Peptides. Supports open access. Articles and issues. Latest issue All issues. Search in this journal. Volume 5, Issue 4 Pages (March ) Download full issue. Previous vol/issue. Next vol/issue. Actions for selected articles. Select all / Deselect all. Vasopressin (arginine vasopressin, AVP) is present in two types of nerve fibres in the median eminence (ME)1–3. F. Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortins.
The corticotropin-releasing activity of synthetic corticoliberin increases 75–90% when it is incubated in the presence of arginine vasopressin with rat anterior pituitary cell suspensions; this suggests a synergistic control of ACTH secretion by vasopressin and corticoliberin. A.J. Baertschi, J.J. Dreifuss (Eds.), Neuroendocrinology of Vasopressin, Corticoliberin, and Opiomelanocortins, Academic Press, New York (), p. Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortins, - Author: Swaab, D.F.; Boer, G.J.; Boer, K.; Oosterbaan, H.P.; Oosting, P.R. Publisher: Netherlands Institute for . In: Neuroendocrinology of vasopressin, corticoliberin and opiomelanocortins. Academic, London Google Scholar Muehlethaler M, Gaehwiler BH, Dreifuss JJ () Enkephalin-induced inhibition of hypothalamic paraventricular neurones.
1. Author(s): Baertschi,A J; Dreifuss,J J; IBRO World Congress,(1st: Lausanne, Switzerland) Title(s): Neuroendocrinology of vasopressin, corticoliberin, and opiomelanocortins/ edited by A.J. Baertschi and J.J. Dreifuss. Country of Publication: England Publisher: London ; New York: Academic Press, Description: xvi, p.: ill. Neuroendocrinology of Vasopressin Corticoliberin and Opiomelanocortins Barker At the Helm: a Laboratory Navigator Barker (Organizer) Strategies for Studying the Roles of Peptides in Neuronal Function. Purchase Endocrinology Neuroendocrinology Neuropeptides - 1st Edition. Print Book & E-Book. ISBN , Vasopressin, also called antidiuretic hormone (ADH), arginine vasopressin (AVP) or argipressin, is a hormone synthesized as a peptide prohormone in neurons in the hypothalamus, and is converted to then travels down the axon of that cell, which terminates in the posterior pituitary, and is released from vesicles into the circulation in response to extracellular fluid hypertonicity.